Using the International Pandemic Instrument to Revitalize the Innovation Ecosystem for Antimicrobial R&D

The inclusion of antimicrobial resistance (AMR) and increased research and development (R&D) capabilities in the most recent outline of the World Health Organization’s (WHO’s) international pandemic instrument signals an opportunity to reshape pharmaceutical R&D system in favour of antimicro...

Descripción completa

Detalles Bibliográficos
Autores principales: Caceres, Andrea Morales, Singh, Kshitij Kumar, Minssen, Timo, Van Katwyk, Susan Rogers, Hoffman, Steven J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Symposium Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009383/
https://www.ncbi.nlm.nih.gov/pubmed/36889345
http://dx.doi.org/10.1017/jme.2022.79
_version_ 1784905972636975104
author Caceres, Andrea Morales
Singh, Kshitij Kumar
Minssen, Timo
Van Katwyk, Susan Rogers
Hoffman, Steven J.
author_facet Caceres, Andrea Morales
Singh, Kshitij Kumar
Minssen, Timo
Van Katwyk, Susan Rogers
Hoffman, Steven J.
author_sort Caceres, Andrea Morales
collection PubMed
description The inclusion of antimicrobial resistance (AMR) and increased research and development (R&D) capabilities in the most recent outline of the World Health Organization’s (WHO’s) international pandemic instrument signals an opportunity to reshape pharmaceutical R&D system in favour of antimicrobial product development. This article explains why the current innovation ecosystem has disadvantaged the creation of antimicrobial products for human use. It also highlights how the COVID-19 pandemic experience can inform and stimulate international cooperation to implement innovative R&D incentives to bring new, life-saving antimicrobial products to the market.
format Online
Article
Text
id pubmed-10009383
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-100093832023-03-14 Using the International Pandemic Instrument to Revitalize the Innovation Ecosystem for Antimicrobial R&D Caceres, Andrea Morales Singh, Kshitij Kumar Minssen, Timo Van Katwyk, Susan Rogers Hoffman, Steven J. J Law Med Ethics Symposium Articles The inclusion of antimicrobial resistance (AMR) and increased research and development (R&D) capabilities in the most recent outline of the World Health Organization’s (WHO’s) international pandemic instrument signals an opportunity to reshape pharmaceutical R&D system in favour of antimicrobial product development. This article explains why the current innovation ecosystem has disadvantaged the creation of antimicrobial products for human use. It also highlights how the COVID-19 pandemic experience can inform and stimulate international cooperation to implement innovative R&D incentives to bring new, life-saving antimicrobial products to the market. Cambridge University Press 2022 /pmc/articles/PMC10009383/ /pubmed/36889345 http://dx.doi.org/10.1017/jme.2022.79 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Symposium Articles
Caceres, Andrea Morales
Singh, Kshitij Kumar
Minssen, Timo
Van Katwyk, Susan Rogers
Hoffman, Steven J.
Using the International Pandemic Instrument to Revitalize the Innovation Ecosystem for Antimicrobial R&D
title Using the International Pandemic Instrument to Revitalize the Innovation Ecosystem for Antimicrobial R&D
title_full Using the International Pandemic Instrument to Revitalize the Innovation Ecosystem for Antimicrobial R&D
title_fullStr Using the International Pandemic Instrument to Revitalize the Innovation Ecosystem for Antimicrobial R&D
title_full_unstemmed Using the International Pandemic Instrument to Revitalize the Innovation Ecosystem for Antimicrobial R&D
title_short Using the International Pandemic Instrument to Revitalize the Innovation Ecosystem for Antimicrobial R&D
title_sort using the international pandemic instrument to revitalize the innovation ecosystem for antimicrobial r&d
topic Symposium Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009383/
https://www.ncbi.nlm.nih.gov/pubmed/36889345
http://dx.doi.org/10.1017/jme.2022.79
work_keys_str_mv AT caceresandreamorales usingtheinternationalpandemicinstrumenttorevitalizetheinnovationecosystemforantimicrobialrd
AT singhkshitijkumar usingtheinternationalpandemicinstrumenttorevitalizetheinnovationecosystemforantimicrobialrd
AT minssentimo usingtheinternationalpandemicinstrumenttorevitalizetheinnovationecosystemforantimicrobialrd
AT vankatwyksusanrogers usingtheinternationalpandemicinstrumenttorevitalizetheinnovationecosystemforantimicrobialrd
AT hoffmanstevenj usingtheinternationalpandemicinstrumenttorevitalizetheinnovationecosystemforantimicrobialrd

Ejemplares similares